Deepak L. Bhatt

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Guidelines for the Early Management of Adults With Ischemic Stroke

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

A Controlled Trial of Renal Denervation for Resistant Hypertension